Assenagon Asset Management S.A. Sells 256,637 Shares of Option Care Health, Inc. $OPCH

Assenagon Asset Management S.A. trimmed its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 87.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 37,761 shares of the company’s stock after selling 256,637 shares during the period. Assenagon Asset Management S.A.’s holdings in Option Care Health were worth $1,203,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in OPCH. Cornerstone Planning Group LLC increased its position in shares of Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after purchasing an additional 1,067 shares in the last quarter. Advisory Services Network LLC purchased a new position in Option Care Health during the 3rd quarter worth $35,000. McIlrath & Eck LLC acquired a new position in Option Care Health during the 2nd quarter valued at about $37,000. Caitong International Asset Management Co. Ltd acquired a new position in Option Care Health during the 3rd quarter valued at about $38,000. Finally, Hantz Financial Services Inc. raised its stake in Option Care Health by 987.7% in the third quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock valued at $39,000 after buying an additional 1,284 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. National Bank Financial set a $37.00 target price on shares of Option Care Health in a research report on Tuesday, January 27th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 29th. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a research note on Tuesday, January 13th. Barrington Research boosted their price target on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Finally, Wall Street Zen lowered Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $37.27.

Option Care Health Stock Performance

Shares of OPCH stock opened at $26.92 on Wednesday. The stock has a market cap of $4.21 billion, a PE ratio of 21.03, a price-to-earnings-growth ratio of 1.51 and a beta of 0.85. The business has a 50-day simple moving average of $32.24 and a 200-day simple moving average of $30.70. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 0.87. Option Care Health, Inc. has a 52-week low of $24.24 and a 52-week high of $36.80.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Option Care Health had a return on equity of 18.57% and a net margin of 3.67%.The firm had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. During the same period last year, the company earned $0.44 earnings per share. Option Care Health’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, equities analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.